Www.aodhealth.org1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.

Slides:



Advertisements
Similar presentations
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Advertisements

Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Accutane-Psychiatric Disorders A Pharmacoepidemiological Safety Assessment Robert C. Nelson, PhD RCN Associates, Inc. Annapolis, MD.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
Sublingual Buprenorphine and Pain
Critical Appraisal of an Article on Therapy. Why critical appraisal? Why therapy?
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July-August 2007.
Journal Club Alcohol and Health: Current Evidence March-April 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Journal Club Alcohol and Health: Current Evidence November–December 2004.
Journal Club Alcohol and Health: Current Evidence May–June 2005.
Journal Club Alcohol and Health: Current Evidence March-April 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence April 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2009.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2011.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2010.
Journal Club Alcohol and Health: Current Evidence May-June 2006.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Journal Club Alcohol and Health: Current Evidence September–October 2004.
Journal Club Alcohol and Health: Current Evidence January-February 2005.
Journal Club Alcohol and Health: Current Evidence September-October 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2014.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2010.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2008.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2009.
Critical Appraisal of an Article on Therapy (2). Formulate Clinical Question Patient/ population Intervention Comparison Outcome (s) Women with IBS Alosetron.
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
DEB BYNUM, MD AUGUST 2010 Evidence Based Medicine: Review of the basics.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2012.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2014.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2012.
LEADING RESEARCH… MEASURES THAT COUNT Challenges of Studying Cardiovascular Outcomes in ADHD Elizabeth B. Andrews, MPH, PhD, VP, Pharmacoepidemiology and.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2015.
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2012.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December, 2015.
G. Biondi Zoccai – Ricerca in cardiologia What to expect? Core modules IntroductionIntroduction Finding out relevant literatureFinding out relevant literature.
Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September–October 2013.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence March–April 2017
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Alcohol, Other Drugs, and Health: Current Evidence March–April 2018
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence July-August, 2018
Alcohol, Other Drugs, and Health: Current Evidence
Alcohol, Other Drugs, and Health: Current Evidence May–June 2019
Presentation transcript:

Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007

Featured Article Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain Edlund MJ, et al. Pain. 2007;129(3):355–362.

Study Objective To identify… risk factors for diagnosed opioid abuse or dependence among chronic opioid users

Study Design Researchers analyzed demographic and clinical data from 15,160 veterans with… –chronic opioid use (>90 day prescription) for noncancer pain but –no diagnosis of an opioid use disorder (opioid abuse or dependence) in their medical records in 2000–2002. Researchers then compared veterans with a subsequent diagnosis of an opioid use disorder in 2003–2005 with veterans without this diagnosis in the same period.

Assessing Validity of an Article About Harm Are the results valid? What are the results? How can I apply the results to patient care?

Are the Results Valid? Did the investigators demonstrate similarity in all known determinants of outcomes? Did they adjust for differences in the analysis? Were exposed patients equally likely to be identified in the two groups? Were the outcomes measured in the same way in the groups being compared? Was follow-up sufficiently complete?

Did the investigators demonstrate similarity in all known determinants of outcomes? Did they adjust for differences in the analysis? All subjects were prescribed opioids. Factors known to be associated with developing prescription drug dependence (substance use disorders and psychiatric comorbidity) were controlled for in the mulitvariable analyses. Multivariable analyses did not adjust for the type of opioid (short vs. long-acting, weak vs. potent) that was prescribed.

Were exposed patients equally likely to be identified in the two groups?  All patients were prescribed opioids.

Were the outcomes measured in the same way in the groups being compared?  Passive surveillance was conducted for ICD-9 diagnoses of opioid abuse or dependence.  There was no attempt to systematically assess patients for opioid abuse or dependence.

Was follow-up sufficiently complete? Follow-up was obtained on all individuals in the cohort at 1–3 years. This may not be sufficient time for a diagnosis of opioid abuse or dependence to be recognized.

What are the Results? How strong is the association between exposure and outcomes? How precise is the estimate of the risk?

What are the Results? From to , 2% were diagnosed with opioid abuse or dependence. In adjusted analyses, veterans with the following in 2002 were more likely to have a subsequent opioid abuse or dependence diagnosis: –nonopioid substance use disorder (OR, 2.34) –mental health disorder (OR, 1.46) –greater number of outpatient healthcare visits (OR, 1.52 for 20+ visits versus 0–6 visits) –greater number of days supplied with opioids (OR, 1.84 for 211+ days versus 91–150 days)

How strong is the association between exposure and outcome? VariableAdjusted Odds Ratios and 95% Confidence Intervals Nonopioid abuse or dependence2.34 ( ) Mental health disorder1.46 ( ) Greater # of outpatient visits1.52 ( ) Greater # of days supplied with opioids 1.84 ( )

How precise is the estimate of the risk? The sample size is large. The confidence intervals are reasonable.

How Can I Apply the Results to Patient Care? Were the study patients similar to the patients in my practice? Was the duration of follow-up adequate? What was the magnitude of the risk? Should I attempt to stop the exposure?

Were the study patients similar to the patients in my practice? 95% were male. 80% were ≥50 years old. All were veterans. 71% were white. 54% had back pain. 45% had a mental health diagnosis. 47% received >211 days of opioids in the first treatment year.

Was the duration of follow-up adequate? No: –1–3 years is a short period of time for an individual’s opioid abuse or dependence to come to clinical recognition.

What was the magnitude of the risk? 2% (298 patients) of the sample had their chronic substance use disorder clinically recognized (diagnosis in medical record).

Should I attempt to stop the exposure? No information is presented on the benefit of the opioid therapy that was prescribed. According to this study, clinicians should assess the benefit of opioid therapy against the potential risk for opioid abuse and dependence… –especially in patients with prior diagnoses of substance use disorders, mental health disorders, high volume of clinic visits, and long-term opioid prescriptions.